ZBH
59
2
USB
44
-2
NI
60
2
SEE
45
-4
MPC
28
2
HPE
38
-15
RCL
79
2
ETR
63
-3
PSA
51
5
CHD
42
-3
ABBV
57
-2
VZ
32
-2
PEP
47
3
AVGO
25
-2
TJX
42
-9
CF
53
3
HSIC
45
8
EXPE
74
2
TRV
46
-3
ES
48
-2
ZBH
59
2
USB
44
-2
NI
60
2
SEE
45
-4
MPC
28
2
HPE
38
-15
RCL
79
2
ETR
63
-3
PSA
51
5
CHD
42
-3
ABBV
57
-2
VZ
32
-2
PEP
47
3
AVGO
25
-2
TJX
42
-9
CF
53
3
HSIC
45
8
EXPE
74
2
TRV
46
-3
ES
48
-2
Financhill
Back

Singular Genomics Systems 10K Form

Buy
69

OMIC
Singular Genomics Systems

Last Price:
22.22
Seasonality Move:
3.28%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive OMIC News And Ratings

See the #1 stock for the next 7 days that we like better than OMIC

OMIC Financial Statistics

Sales & Book Value

Annual Sales: $2.91M
Cash Flow: $-18.04M
Price / Cash Flow: 0
Annual Sales: $55.27
Price / Book: 0.4

Profitability

EPS (TTM): -37.37000
Net Income (TTM): $-91.89M
Gross Margin: $-558K
Return on Equity: -51.57%
Return on Assets: -35.53%

Singular Genomics Systems Earnings Forecast

Key Singular Genomics Systems Financial Ratios

  • The Gross Profit Margin over the past 3 years for OMIC is -19.17%.
  • The Selling, General & Administrative Expenses for OMIC have been equal to 1,871.49% of Gross Profit Margin.
  • The Research & Development expenses have been 1,640.81% of Revenue.
  • The Interest Expense is -1.16% of Operating Income.
  • The Net Earning history of OMIC is -3,257.30% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 1 years.

Singular Genomics Systems Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: OMIC
Website: singulargenomics.com

Debt

Debt-to-Equity Ratio: 0.05
Current Ratio: 8.77
Quick Ratio: 7.94

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

OMIC Technical Analysis vs Fundamental Analysis

Buy
69
Singular Genomics Systems (OMIC) is a Buy

Is Singular Genomics Systems a Buy or a Sell?